Answers are grounded in this paper and cite their sources.
Under ultralow radiofrequency (RF) power, transferrin-conjugated graphene nanoparticles can thermally ablate drug- or radiation-resistant cancer cells very effectively. The results suggest that graphene-based RF hyperthermia can be an efficient method to manage drug-/radiation-resistant cancers.
No takes yet. Share an insight, caveat, or question.
Sasidharan et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: